Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1044591-98-1

Post Buying Request

1044591-98-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1044591-98-1 Usage

General Description

(R)-3-methoxycarbonyl-(R)-5-methylpiperidine is a chemical compound with the molecular formula C9H17NO2. It is a piperidine derivative containing a methoxycarbonyl group and a methyl substituent on the piperidine ring. (R)-3-methoxycarbonyl-(R)-5-methylpiperidine is used in the pharmaceutical industry for the synthesis of various drugs, particularly those targeting the central nervous system. It has also been studied for its potential use as a chiral building block in organic synthesis. As a chiral compound, it exhibits optical activity, and its enantiomers may have different pharmacological properties. Further research and development of this compound may lead to new pharmaceuticals and chemical products.

Check Digit Verification of cas no

The CAS Registry Mumber 1044591-98-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,4,4,5,9 and 1 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1044591-98:
(9*1)+(8*0)+(7*4)+(6*4)+(5*5)+(4*9)+(3*1)+(2*9)+(1*8)=151
151 % 10 = 1
So 1044591-98-1 is a valid CAS Registry Number.

1044591-98-1Relevant articles and documents

1,5-Substituted nipecotic amides: Selective PDE8 inhibitors displaying diastereomer-dependent microsomal stability

DeNinno, Michael P.,Wright, Stephen W.,Visser, Michael S.,Etienne, John B.,Moore, Dianna E.,Olson, Thanh V.,Rocke, Benjamin N.,Andrews, Melissa P.,Zarbo, Cynthia,Millham, Michele L.,Boscoe, Brian P.,Boyer, David D.,Doran, Shawn D.,Houseknecht, Karen L.

, p. 3095 - 3098 (2011)

The first highly potent and selective PDE8 inhibitors are disclosed. The initial tetrahydroisoquinoline hit was transformed into a nipecotic amide series in order to address a reactive metabolite issue. Reduction of lipophilicity to address metabolic liab

PYRAZINYLPYRIDINES USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES

-

Page/Page column 79, (2011/04/14)

The present invention provides a compound of Formula (I) and pharmaceutically acceptable salts thereof. Also provided is a method of using a compound of Formula I for treating a disease or condition mediated by a CDK inhibitor.

HETEROARYL COMPOUNDS AS KINASE INHIBITORS

-

Page/Page column 79-80, (2011/04/14)

The present invention provides a compound of Formula (I): and pharmaceutically acceptable salts thereof. Also provided is a method of using a compound of Formula I for treating a disease or condition mediated by a CDK inhibitor

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1044591-98-1